TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY
JANUARY EDITION
|
|
|
|
In this article, Fran DeGrazio highlights 5 drug delivery challenges that were commonly discussed by industry insiders throughout 2024.
|
|
|
|
Explore why you should develop a regulatory strategy that incorporates key enablers of market success from early clinical studies, through the marketing application, to post-market changes.
|
|
|
|
2025 will be the year for pharmaceutical companies to revisit their drug delivery device strategies or risk being left behind. Here are the five reasons why.
|
|
|
|
Learn more about PFAs in medical devices, covering environmental concerns, health risks, testing, alternatives and management strategies with Shalene Thomas of Battelle.
|
|
|
|
Current challenges in Europe's medical device market include the EU MDR transition and a lack of harmonization. Device manufacturers, regulators, and other stakeholders can take these key actions to create positive change.
|
|
|
|